Savarino V et al. |
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10886045
|
Saito K et al. |
Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma. |
2000 |
Gastrointest. Endosc. |
pmid:10882958
|
Yanagihara K et al. |
Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation. |
2000 |
J. Antimicrob. Chemother. |
pmid:10882691
|
Delchier JC |
[How to eradicate Helicobacter pylori?]. |
1999 |
Gastroenterol. Clin. Biol. |
pmid:10880913
|
Erel F et al. |
Impact of Helicobacter pylori and Giardia lamblia infections on chronic urticaria. |
2000 Mar-Apr |
J Investig Allergol Clin Immunol |
pmid:10879997
|
Suzuki K et al. |
[Fibrosing alveolitis following Legionella pneumonia]. |
2000 |
Nihon Kokyuki Gakkai Zasshi |
pmid:10879037
|
Maggiolo F et al. |
In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus. |
2000 |
J Chemother |
pmid:10877512
|
Amayasu H et al. |
Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. |
2000 |
Ann. Allergy Asthma Immunol. |
pmid:10875487
|
Fraser AG et al. |
Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit. |
1999 |
Aust N Z J Med |
pmid:10868529
|
Mikasa K |
[Study of effects and mechanisms of macrolide as biological response modifier for lung cancer treatment]. |
2000 |
Jpn J Antibiot |
pmid:10868303
|
Drago L et al. |
Comparative effect of thiamphenicol glycinate, thiamphenicol glycinate N-acetylcysteinate, amoxicillin plus clavulanic acid, ceftriaxone and clarithromycin on pulmonary clearance of Haemophilus influenzae in an animal model. |
2000 Jul-Aug |
Chemotherapy |
pmid:10859433
|
Miltner EC and Bermudez LE |
Mycobacterium avium grown in Acanthamoeba castellanii is protected from the effects of antimicrobials. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858369
|
Hirschl AM et al. |
In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858365
|
Hammerschlag MR and Roblin PM |
Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae. |
2000 |
Int. J. Antimicrob. Agents |
pmid:10854812
|
Nagahara A et al. |
Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy. |
2000 |
Helicobacter |
pmid:10849057
|
Bhasin DK et al. |
Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India. |
2000 |
Helicobacter |
pmid:10849056
|
Leiper K et al. |
Open label trial of oral clarithromycin in active Crohn's disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848665
|
Ammon S et al. |
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848660
|
Katelaris PH et al. |
Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848659
|
Moayyedi P et al. |
The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme. Leeds Help Study Group. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848655
|
Zullo A et al. |
A new highly effective short-term therapy schedule for Helicobacter pylori eradication. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10848654
|
Baños F et al. |
[Effectiveness of omeprazole, clarithromycin and amoxycillin therapy to eradicate Helicobacter pylori in patients with active peptic ulcer. Preliminary results of GENPY study]. |
2000 |
Med Clin (Barc) |
pmid:10846695
|
Romero Gómez M et al. |
[Usefulness of Helicobacter pylori antigen detection in stools in the diagnosis of infection and confirming eradication after treatment]. |
2000 |
Med Clin (Barc) |
pmid:10846675
|
Laine L et al. |
Endoscopic biopsy requirements for post-treatment diagnosis of Helicobacter pylori. |
2000 |
Gastrointest. Endosc. |
pmid:10840297
|
Kaushik SP and Vu C |
Helicobacter pylori eradication with lansoprazole, amoxycillin and clarithromycin: testing an ideal regimen in a multicultural south east Asian population and examining factors potentially influencing eradication. |
2000 |
Aust N Z J Med |
pmid:10833116
|
Gisbert JP et al. |
One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. |
2000 |
Eur J Gastroenterol Hepatol |
pmid:10833090
|
Miyashita N et al. |
In vitro susceptibility of 7.5-kb common plasmid-free Chlamydia trachomatis strains. |
2000 |
Microbiol. Immunol. |
pmid:10832970
|
Spiegel JR et al. |
Prolonged ulcerative laryngitis. |
2000 |
Ear Nose Throat J |
pmid:10832196
|
Flockhart DA et al. |
Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome. |
2000 |
J Clin Psychopharmacol |
pmid:10831018
|
Zuckerman JM |
The newer macrolides: azithromycin and clarithromycin. |
2000 |
Infect. Dis. Clin. North Am. |
pmid:10829265
|
Rhee CS et al. |
Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis. |
2000 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10823478
|
Suzuki H et al. |
Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. |
2000 May-Jun |
ORL J. Otorhinolaryngol. Relat. Spec. |
pmid:10810255
|
Azuma T et al. |
Pharmacokinetics of clarithromycin in Helicobacter pylori eradication therapy in patients with liver cirrhosis. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10807427
|
Boruchoff SE et al. |
The steady-state disposition of indinavir is not altered by the concomitant administration of clarithromycin. |
2000 |
Clin. Pharmacol. Ther. |
pmid:10801243
|
Boyanova L et al. |
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria. |
2000 |
J. Med. Microbiol. |
pmid:10798553
|
Vernet Vernet M et al. |
[Analysis of indications and diagnosis of the gastroscopies requested by primary care physicians]. |
2000 |
Aten Primaria |
pmid:10795440
|
Shimizu T et al. |
Successful treatment using clarithromycin for a cutaneous lesion caused by Mycobacterium szulgai. |
2000 |
Br. J. Dermatol. |
pmid:10792258
|
Calvet X et al. |
A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10792124
|
Marini RP et al. |
Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets. |
1999 |
Am. J. Vet. Res. |
pmid:10791942
|
Waites K et al. |
Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children. |
2000 |
J. Clin. Microbiol. |
pmid:10790089
|
Shibl AM et al. |
Penicillin-resistant and -intermediate Streptococcus pneumoniae in Saudi Arabia. |
2000 |
J Chemother |
pmid:10789552
|
Kane CL et al. |
Disseminated cutaneous Mycobacterium chelonae infection. |
2000 Mar-Apr |
Cancer Control |
pmid:10783823
|
Abisheganaden JA et al. |
Effect of clarithromycin on experimental rhinovirus-16 colds: a randomized, double-blind, controlled trial. |
2000 |
Am. J. Med. |
pmid:10781777
|
Fujimura S et al. |
Clarithromycin-susceptible Helicobacter pylori with mutation in 23S rRNA gene by PCR-RFLP method. |
2000 |
J. Gastroenterol. |
pmid:10777165
|
Najib MM et al. |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia. |
2000 |
Pharmacotherapy |
pmid:10772376
|
Singer J et al. |
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group. |
2000 |
Int J STD AIDS |
pmid:10772083
|
Adamsson I et al. |
Microbial ecology and treatment of Helicobacter pylori infections: review. |
2000 |
J Chemother |
pmid:10768510
|
Bojarski C et al. |
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out. |
2000 |
Z Gastroenterol |
pmid:10768243
|
Offman E et al. |
Oral absorption of clarithromycin in acute illness and during convalescence in patients with community-acquired pneumonia. |
2000 |
Chest |
pmid:10767245
|
Gasbarrini A et al. |
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus. |
2000 |
Scand. J. Gastroenterol. |
pmid:10766318
|